Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TREATT PLC Director's Dealing 2019

Jan 17, 2019

4700_dirs_2019-01-17_0527cdee-07fd-499a-b812-d5145fc55261.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4357N

Treatt PLC

17 January 2019

17 January 2019

TREATT PLC

("Treatt" or "the Company")

Notification of Transactions of Directors

In accordance with the requirements of the EU Market Abuse Regulation, the Company was notified today that on 17 January 2019, Daemmon Reeve bought 4,185 ordinary shares of the Company registered in the name of Lawshares Nominees Limited, at an aggregated price of £4.24.

Details of the Director
a) Name Daemmon Reeve
2 Reason for the notification
a) Position/status CEO
b) Initial notification/Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Treatt Plc
b) LEI 213800G40JM9F7G9LG39
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 2 pence each

GB00BKS7YK08
b) Nature of transaction Purchase of ordinary shares to be held in the name of Lawshares Nominees Limited
c) Price(s) and volume(s) Price(s) Volume(s)
£4.24 4,185
Aggregated information

-      Aggregated volume

-      Price
N/A (Single transaction)
e) Date of the transaction 17 January 2019
f) Place of the transaction London Stock Exchange, XLON

Contact details

Anita Steer

Company Secretary

++ 44 1284 770028

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBRGDBXGBBGCR